Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Marchetti

Showing results (241-250 of 450) with videos related to

Pageof 45
Sort By:
Anti-Cancer Drugs|August 25, 2016
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancerAdriana Romiti, Michela Roberto, Chiara D'Antonio, et al.
Nuclear Medicine Communications|March 11, 2010
Intradermal lymphoscintigraphy at rest and after exercise: a new technique for the functional assessment of the lymphatic system in patients with lymphoedemaGirolamo Tartaglione, Marco Pagan, Roberto Morese, et al.
Critical Reviews in Oncology/Hematology|July 7, 2020
The 5-Ws of immunotherapy in head and neck cancerAndrea Botticelli, Silvia Mezi, Giulia Pomati, et al.
Frontiers in Pharmacology|January 22, 2026
Hematologic immune-related adverse events in skin cancer patients treated with immune checkpoint inhibitors: a case seriesRosa Falcone, Alessandra Frezzolini, Emanuele Bruni, et al.
Critical Reviews in Oncology/Hematology|December 8, 2015
Current challenges in HER2-positive breast cancerFabio Puglisi, Caterina Fontanella, Vito Amoroso, et al.
Plos One|September 23, 2016
Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?Andrea Botticelli, Marina Borro, Concetta Elisa Onesti, et al.
Frontiers in Immunology|August 1, 2020
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1Andrea Botticelli, Silvia Mezi, Giulia Pomati, et al.
Cancer Management and Research|March 1, 2021
Oxycodone/Acetaminophen: The Tailoring Combination Treatment for Specific Clinical Profile of Opioid Well-Responsive Cancer PainStefano De Santis, Maria Domenica Simone, Sebastiano Mercadante, et al.
International Journal of Molecular Sciences|August 26, 2022
Synthesis and NLRP3-Inflammasome Inhibitory Activity of the Naturally Occurring Velutone F and of Its Non-Natural Regioisomeric ChalconoidsTiziano De Ventura, Mariasole Perrone, Sonia Missiroli, et al.
Journal of Personalized Medicine|August 6, 2021
The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot StudyAndrea Botticelli, Ilaria Grazia Zizzari, Simone Scagnoli, et al.
Pageof 45

Showing results (241-250 of 450) with videos related to

Sort By:
Pageof 45
Anti-Cancer Drugs|August 25, 2016
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancerAdriana Romiti, Michela Roberto, Chiara D'Antonio, et al.
Nuclear Medicine Communications|March 11, 2010
Intradermal lymphoscintigraphy at rest and after exercise: a new technique for the functional assessment of the lymphatic system in patients with lymphoedemaGirolamo Tartaglione, Marco Pagan, Roberto Morese, et al.
Critical Reviews in Oncology/Hematology|July 7, 2020
The 5-Ws of immunotherapy in head and neck cancerAndrea Botticelli, Silvia Mezi, Giulia Pomati, et al.
Frontiers in Pharmacology|January 22, 2026
Hematologic immune-related adverse events in skin cancer patients treated with immune checkpoint inhibitors: a case seriesRosa Falcone, Alessandra Frezzolini, Emanuele Bruni, et al.
Critical Reviews in Oncology/Hematology|December 8, 2015
Current challenges in HER2-positive breast cancerFabio Puglisi, Caterina Fontanella, Vito Amoroso, et al.
Plos One|September 23, 2016
Degradation Rate of 5-Fluorouracil in Metastatic Colorectal Cancer: A New Predictive Outcome Biomarker?Andrea Botticelli, Marina Borro, Concetta Elisa Onesti, et al.
Frontiers in Immunology|August 1, 2020
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1Andrea Botticelli, Silvia Mezi, Giulia Pomati, et al.
Cancer Management and Research|March 1, 2021
Oxycodone/Acetaminophen: The Tailoring Combination Treatment for Specific Clinical Profile of Opioid Well-Responsive Cancer PainStefano De Santis, Maria Domenica Simone, Sebastiano Mercadante, et al.
International Journal of Molecular Sciences|August 26, 2022
Synthesis and NLRP3-Inflammasome Inhibitory Activity of the Naturally Occurring Velutone F and of Its Non-Natural Regioisomeric ChalconoidsTiziano De Ventura, Mariasole Perrone, Sonia Missiroli, et al.
Journal of Personalized Medicine|August 6, 2021
The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot StudyAndrea Botticelli, Ilaria Grazia Zizzari, Simone Scagnoli, et al.
Pageof 45